Sign in
4

Changes in Ownership

Equillium, Inc. Filed Acc 0001415889-25-004762

Options or other derivatives

  • Chief Scientific Officer acquired 585,034 shares (grant or award)
  • Chief Scientific Officer returned 585,034 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +90,000 90,000 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −90,000 0 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +52,500 52,500 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −52,500 0 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −100,000 0 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +42,534 42,534 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −42,534 0 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +125,000 125,000 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −125,000 0 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Grant or award · Employee Stock Option (right to buy) +175,000 175,000 D
Connelly Stephen Chief Scientific Officer 2025-02-14 Returned to the company · Employee Stock Option (right to buy) −175,000 0 D
Loading xslF345X05/form4-02202025_120238.xml…